Twitter
Linkedin
CRISPR-Cas9
Intellectual Property
Licensing
Knowledge Centre
News
Our Team
Contact Us
Menu
CRISPR-Cas9
Intellectual Property
Licensing
Knowledge Centre
News
Our Team
Contact Us
The global CRISPR/Cas9
licensing leader
Based on the Nobel Prize winning invention of
Emmanuelle Charpentier & Jennifer Doudna,
CRISPR/Cas9 has transformed gene editing.
ERS licenses worldwide access to the essential
CRISPR/Cas9 patent portfolio
Contact us to discuss a license
"This is transformative technology that allows the recoding of life and editing"
Emmanuelle Charpentier
ERS co-founder, patent co-owner
& 2020 Nobel prize winner
The essential intellectual property for the practice of CRISPR/Cas9
Consisting of over 85 issued patents in over 80 countries, our portfolio represents the most foundational collection of CRISPR/Cas9 patents worldwide.
Learn More
Latest news
Foundational CRISPR/Cas9 gene editing patent granted to CVC in Canada
Posted on
5 January 2023
11 January 2023
Read More
Crown Bioscience & ERS Genomics Announce Global CRISPR/Cas9 Licensing Agreement for Genome Editing Patents
Posted on
8 December 2022
7 December 2022
Read More
New CRISPR/Cas9 license agreement for ERS Genomics and Cosmo Bio
Posted on
1 December 2022
30 November 2022
Read More
New CRISPR/Cas9 Agreement for ERS Genomics and ATLATL
Posted on
18 November 2022
17 November 2022
Read More
Gene editing Webinar: Navigating IP, deal-making and regulatory challenges
Posted on
17 November 2022
17 November 2022
Read More
ERS Genomics and Lepton Pharmaceuticals LTD Enter CRISPR/Cas9 License Agreement
Posted on
26 July 2022
25 July 2022
Read More
New CRISPR/Cas9 license agreement for ERS Genomics and Cytosurge
Posted on
28 June 2022
28 June 2022
Read More
Advances for India as foundational CRISPR/Cas9 gene editing patent granted
Posted on
13 June 2022
13 June 2022
Read More
Patent upheld, ERS leadership position in European CRISPR Landscape confirmed
Posted on
31 May 2022
30 May 2022
Read More
Sumitomo Pharma takes license to CRISPR/Cas9 patent portfolio from ERS Genomics
Posted on
26 April 2022
26 April 2022
Read More